SCHEMBL7975299

SCHEMBL7975299

C#Cc1ccc(C(=O)NN2CCN(C(C)=O)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.48
GAA P10253 1/20 0.44
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
AKR1C3 P42330 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958989 0.86 AURKA (0.48) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL8018069 0.82 CYP2D6 (0.53) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL7972839 0.82 CYP2D6 (0.53) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL194951 0.81 CYP2D6 (0.72) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL14590778 0.80 HTT (0.65) CYP2D6GAAHTTSMN1; SMN2MAPT
SCHEMBL7968909 0.79 CYP2D6 (0.50) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
Water SCHEMBL3089403 0.79 CYP2D6 (0.70) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL7975155 0.78 HPGD (0.50) CYP2D6GAAHTTSMN1; SMN2ALDH1A1
SCHEMBL7972482 0.78 CYP2D6 (0.49) CYP2D6HTTALDH1A1HPGDMAPT
SCHEMBL7970177 0.78 PLK1 (0.50) CYP2D6GAAHTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291464-B1 POTENTIATION OF THE CHOLINERGIC ACTIVITY; THERAPEUTIC TREATMENT OF AMNESIA, DEMENTIA OR SENILE DEMENTIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-18 US disclosed
EP-0968201-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-05 EP disclosed
WO-1998035951-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-08-20 WO disclosed